SCHEMBL25101457

SCHEMBL25101457

Cc1cc(N2CCCc3cc(OC(C)C)c(F)cc3C2)cc(C)c1NC(=O)CC(C)(C)C

nearest known ligand 0.62

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ KCNQ2 O43526 20/20 0.62
▸ KCNQ3 O43525 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30205870 1.00 KCNQ2 (0.62) KCNQ2KCNQ3
SCHEMBL25101353 0.92 KCNQ2 (0.60) KCNQ2KCNQ3
SCHEMBL30205869 0.92 KCNQ2 (0.60) KCNQ2KCNQ3
SCHEMBL30205851 0.92 KCNQ2 (0.60) KCNQ2KCNQ3
SCHEMBL25101340 0.92 KCNQ2 (0.60) KCNQ2KCNQ3
SCHEMBL25101349 0.92 KCNQ2 (0.60) KCNQ2KCNQ3
SCHEMBL25101368 0.92 KCNQ2 (0.60) KCNQ2KCNQ3
SCHEMBL25101298 0.92 KCNQ2 (0.60) KCNQ2KCNQ3
SCHEMBL25101348 0.92 KCNQ2 (0.60) KCNQ2KCNQ3
SCHEMBL30206307 0.92 KCNQ2 (0.60) KCNQ2KCNQ3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4393907-A1 POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION Neushen Therapeutics (Shanghai) Co., Ltd (CN) 2024-07-03 — — EP disclosed
CN-115724799-A Potassium channel regulator, composition and application 杭州和正医药有限公司 2023-03-03 — — CN disclosed
WO-2023025276-A1 POTASSIUM CHANNEL MODULATOR, COMPOSITION AND APPLICATION 杭州和正医药有限公司 2023-03-02 — — WO disclosed
Send feedback